Skinhealth Systems Inc. revenue
Skinhealth Systems Inc.'s revenue was $301m in fiscal 2025, down 10.0% on the year before. Since fiscal 2019 ($167m) it has grown at a compound 10.3% a year. Over the last twelve months it was $290m.
Revenue history
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 167 | 119 | 260 | 366 | 398 | 334 | 301 | 290 |
| Growth on the year before | — | −28.5% | +118.4% | +40.7% | +8.8% | −16.0% | −10.0% | — |
| Gross profit | 107 | 67 | 179 | 249 | 155 | 182 | 196 | 192 |
| Gross margin | 63.9% | 56.4% | 68.6% | 68.0% | 39.0% | 54.5% | 65.3% | 66.4% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Consumables | $213M | 70.7% | ▲ 1.8% |
| Delivery Systems | $88.1M | 29.3% | ▼ 29.8% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| Americas | $204M | 67.8% | ▼ 6.0% |
| EMEA | $68.3M | 22.7% | ▼ 4.7% |
| Asia Pacific | $28.5M | 9.5% | ▼ 37.6% |
From Skinhealth Systems Inc.'s 10-K filed March 12, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Skinhealth Systems Inc. | $290m | -6.5% | -9.5% |
| Axogen, Inc. | $267m | 24.3% | 20.6% |
| Orthopediatrics Corp | $264m | 16.1% | 23.0% |
| Lemaitre Vascular Inc | $262m | 11.8% | 14.0% |
| Angiodynamics Inc | $325m | 8.2% | -1.1% |
| Cerus Corp | $254m | 74.6% | 89.8% |
Compare with peers
- Axogen, Inc. revenue
- Orthopediatrics Corp revenue
- Lemaitre Vascular Inc revenue
- Angiodynamics Inc revenue
- Cerus Corp revenue
Head to head: AXGN vs SKINKIDS vs SKINLMAT vs SKIN
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies